Skip to content
Use caution Drug recall · FDA · Published March 25, 2016

Bryant Ranch Recalls Venlafaxine Due to Label Mix-Up

Bryant Ranch Prepack recalls Venlafaxine 75 mg tablets because they were incorrectly labeled as immediate-release instead of extended-release.

🇺🇸 FDA recall #D-0837-2016DrugBryant Ranch Prepack ›
Take action

Contact the company

Recalling firmBryant Ranch Prepack Inc.1919 N Victory Pl · Burbank, CA 91504-3425
✎ GovInfoNow plain-language explainer

What happened, in plain English

Bryant Ranch Prepack, Inc. is recalling specific lots of Venlafaxine 75 mg tablets (Compare to Effexor) due to a labeling error. The product was manufactured by Teva Pharmaceuticals but repackaged and incorrectly labeled as an immediate-release formulation when it is actually extended-release. This affects two bottle sizes: 30-count (NDC 636290-3324-2) and 100-count (NDC 63629-3324-6). Read more at govinfonow.com/recall/43064-bryant-ranch-recalls-venlafaxine-due-to-label-mix-up.

Source Summary by GovInfoNow · govinfonow.com/recall/43064-bryant-ranch-recalls-venlafaxine-due-to-label-mix-up · Updated October 11, 2026 · FDA enforcement record: FDA #D-0837-2016

Cite this page

“Bryant Ranch Recalls Venlafaxine Due to Label Mix-Up.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43064-bryant-ranch-recalls-venlafaxine-due-to-label-mix-up. Based on FDA recall #D-0837-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0837-2016%22&limit=1).

Why it’s dangerous

The core hazard is a labeling mix-up where extended-release tablets were labeled as immediate-release. Taking extended-release medication as if it were immediate-release can result in receiving too much medication at once or disrupting the intended slow-release mechanism, which may lead to adverse health effects or reduced efficacy.

Who’s affected

Patients who have been prescribed or purchased Venlafaxine 75 mg tablets from the affected lots. Individuals relying on the immediate-release dosing schedule may inadvertently take a dose intended for extended release, potentially leading to incorrect medication intake.

How to tell if you have this one

Check your bottle for the following details: NDC 636290-3324-2 (30-count) or NDC 63629-3324-6 (100-count). Verify the lot number is 94983 and the expiration date is 10/17. The label should state 'Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet' and indicate it was manufactured by Teva Pharmaceuticals USA, Inc. and packaged by Bryant Ranch.

  • Brand
    Bryant Ranch Prepack
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your Venlafaxine 75 mg tablets match the NDC numbers, lot number 94983, and expiration date 10/17 listed in the recall.

  2. Contact Your Pharmacist

    Speak with your healthcare provider or pharmacist immediately to discuss how to safely manage your dosage given the labeling error.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Mar 25, 201612. FDA classified it Class III: May 4, 201623. Published in FDA’s Enforcement Report: May 11, 201634. FDA terminated the recall: Aug 29, 201642016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0837-2016 (March 25, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0837-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA